PHS
ABBV icon

PFM Health Sciences’s AbbVie ABBV Stock Holding History

PFM Health Sciences’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100,000
Closed -$16.2M – 80
2022
Q4 		$16.2M Buy
+100,000
New +$15.3M 0.58% 57
2020
Q3 		– Sell
-366,800
Closed -$36M – 76
2020
Q2 		$36M Buy
+366,800
New +$32.3M 1.87% 17
2016
Q2 		– Sell
-930,600
Closed -$53.2M – 79
2016
Q1 		$53.2M Buy
+930,600
New +$51.9M 1.64% 24

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFM Health Sciences's ABBV Position: Q3 2025 in Review

PFM Health Sciences sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 40,782 shares — an estimated $7.57M sold.

PFM Health Sciences first reported a position in ABBV in Q1 2016 and held it in 27 quarters. The position peaked at $137M in Q1 2016. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • PFM Health Sciences reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • PFM Health Sciences sold 40,782 AbbVie shares in Q3 2025, an estimated $7.57M.
  • PFM Health Sciences first reported a position in AbbVie in Q1 2016 and held it in 27 quarters.
  • PFM Health Sciences's AbbVie position peaked at $137M in Q1 2016.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.